These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20027385)

  • 1. Adverse drug events in hospitals: a systematic review.
    Cano FG; Rozenfeld S
    Cad Saude Publica; 2009; 25 Suppl 3():S360-72. PubMed ID: 20027385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic-associated adverse drug events at a Japanese academic hospital.
    Kokado R; Hagiya H; Koyama T; Matsui E; Okuno H; Morii D; Hamaguchi S; Yoshida H; Miwa Y; Tomono K
    J Infect Chemother; 2019 May; 25(5):392-395. PubMed ID: 30497807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of accuracy of IHI Trigger Tool in identifying adverse drug events: a prospective observational study.
    Silva MDDG; Martins MAP; Viana LG; Passaglia LG; de Menezes RR; Oliveira JAQ; da Silva JLP; Ribeiro ALP
    Br J Clin Pharmacol; 2018 Oct; 84(10):2252-2259. PubMed ID: 29874704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for hospital admissions associated with adverse drug events.
    Kongkaew C; Hann M; Mandal J; Williams SD; Metcalfe D; Noyce PR; Ashcroft DM
    Pharmacotherapy; 2013 Aug; 33(8):827-37. PubMed ID: 23686895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quick assessment of drug-related admissions over time (QUADRAT study).
    Warlé-van Herwaarden MF; Valkhoff VE; Herings RM; Engelkes M; van Blijderveen JC; Rodenburg EM; de Bie S; Alsma J; van de Steeg-Gompel C; Kramers C; Meyboom RH; Sturkenboom MC; De Smet PA
    Pharmacoepidemiol Drug Saf; 2015 May; 24(5):495-503. PubMed ID: 25683383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse Drug Event Rate in Israeli Hospitals: Validation of an International Trigger Tool and an International Comparison Study.
    Zimlichman E; Gueta I; Daliyot D; Ziv A; Oberman B; Hochman O; Tamir O; Tal O; Loebstein R
    Isr Med Assoc J; 2018 Nov; 20(11):665-669. PubMed ID: 30430793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug events identified by triggers at a teaching hospital in Brazil.
    Giordani F; Rozenfeld S; Martins M
    BMC Pharmacol Toxicol; 2014 Dec; 15():71. PubMed ID: 25496209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug events identified in hospitalized patients in Brazil by International Classification of Diseases (ICD-10) code listings.
    Martins AC; Giordani F; Guaraldo L; Tognoni G; Rozenfeld S
    Cad Saude Publica; 2018 Nov; 34(12):e00222417. PubMed ID: 30517319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug events among adult inpatients: a meta-analysis of observational studies.
    Martins AC; Giordani F; Rozenfeld S
    J Clin Pharm Ther; 2014 Dec; 39(6):609-20. PubMed ID: 25219403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
    Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
    Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical prediction rule to identify high-risk inpatients for adverse drug events: the JADE Study.
    Sakuma M; Bates DW; Morimoto T
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1221-6. PubMed ID: 22887972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of medication-related adverse events in inpatients-a systematic review and meta-analysis.
    Laatikainen O; Miettunen J; Sneck S; Lehtiniemi H; Tenhunen O; Turpeinen M
    Eur J Clin Pharmacol; 2017 Dec; 73(12):1539-1549. PubMed ID: 28871436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a computer-based adverse-drug-event monitor.
    Hwang SH; Lee S; Koo HK; Kim Y
    Am J Health Syst Pharm; 2008 Dec; 65(23):2265-72. PubMed ID: 19020194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of drug-related adverse events in hospitals.
    Thürmann PA
    Expert Opin Drug Saf; 2003 Sep; 2(5):447-9. PubMed ID: 12946244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Adverse Events With Antibiotic Use in Hospitalized Patients.
    Tamma PD; Avdic E; Li DX; Dzintars K; Cosgrove SE
    JAMA Intern Med; 2017 Sep; 177(9):1308-1315. PubMed ID: 28604925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-related visits to the medical emergency department: a prospective study from India.
    Malhotra S; Jain S; Pandhi P
    Int J Clin Pharmacol Ther; 2001 Jan; 39(1):12-8. PubMed ID: 11204932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence and preventability of adverse drug events in surgical patients: a systematic review of literature.
    Boeker EB; de Boer M; Kiewiet JJ; Lie-A-Huen L; Dijkgraaf MG; Boermeester MA
    BMC Health Serv Res; 2013 Sep; 13():364. PubMed ID: 24074346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and preventability of adverse drug events in hospitalized adults.
    Bates DW; Leape LL; Petrycki S
    J Gen Intern Med; 1993 Jun; 8(6):289-94. PubMed ID: 8320571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A data-driven method to detect adverse drug events from prescription data.
    Zhan C; Roughead E; Liu L; Pratt N; Li J
    J Biomed Inform; 2018 Sep; 85():10-20. PubMed ID: 30016721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying Medication-Related Adverse Drug Events in Nursing Facilities in East Texas.
    Tenhunen ML; Smithers B; Tucker B
    Consult Pharm; 2016; 31(8):436-9. PubMed ID: 27535078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.